These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 28516949)

  • 21. Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations.
    Madkaikar M; Gupta M; Jijina F; Ghosh K
    Eur J Haematol; 2009 Dec; 83(6):503-11. PubMed ID: 19686268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular genetics, biochemistry, and biology of PNH].
    Kinoshita T
    Rinsho Ketsueki; 2017; 58(4):353-362. PubMed ID: 28484166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria.
    Sloand EM; Mainwaring L; Keyvanfar K; Chen J; Maciejewski J; Klein HG; Young NS
    Blood; 2004 Dec; 104(12):3782-8. PubMed ID: 15304386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target.
    Risitano AM; Frieri C; Urciuoli E; Marano L
    Immunol Rev; 2023 Jan; 313(1):262-278. PubMed ID: 36110036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
    Shingai N; Mizumaki H; Najima Y; Yamada Y; Tran DC; Haraguchi K; Toya T; Okuyama Y; Doki N; Nannya Y; Ogawa S; Nakao S
    Front Immunol; 2023; 14():1329403. PubMed ID: 38288112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paroxysmal nocturnal hemoglobinuria: from physiopathology to treatment].
    Arruda MM; Rodrigues CA; Yamamoto M; Figueiredo MS
    Rev Assoc Med Bras (1992); 2010; 56(2):214-21. PubMed ID: 20498998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.
    Brodsky RA; Vala MS; Barber JP; Medof ME; Jones RJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8756-60. PubMed ID: 9238050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxysmal nocturnal haemoglobinuria: the disease and a hypothesis for a new treatment.
    Jarva H; Meri S
    Scand J Immunol; 1999 Feb; 49(2):119-25. PubMed ID: 10075014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paroxysmal nocturnal hemoglobinuria].
    Peffault de Latour R; Amoura Z; Socié G
    Rev Med Interne; 2010 Mar; 31(3):200-7. PubMed ID: 19303177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A SIN lentiviral vector containing PIGA cDNA allows long-term phenotypic correction of CD34+-derived cells from patients with paroxysmal nocturnal hemoglobinuria.
    Robert D; Mahon FX; Richard E; Etienne G; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2003 Mar; 7(3):304-16. PubMed ID: 12668126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.
    Ebenbichler CF; Würzner R; Sandhofer AD; Niederwieser D; Dierich MP; Patsch JR
    Immunobiology; 1996-1997; 196(5):513-21. PubMed ID: 9145329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria.
    Merrill SA; Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):371-376. PubMed ID: 30504334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria].
    Villegas A; Arrizabalaga B; Bonanad S; Colado E; Gaya A; González A; Jarque I; Núñez R; Ojeda E; Orfao A; Ribera JM; Vicente V; Urbano-Ispizua Á;
    Med Clin (Barc); 2016 Mar; 146(6):278.e1-7. PubMed ID: 26895645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
    Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
    Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.
    Johnston JJ; Gropman AL; Sapp JC; Teer JK; Martin JM; Liu CF; Yuan X; Ye Z; Cheng L; Brodsky RA; Biesecker LG
    Am J Hum Genet; 2012 Feb; 90(2):295-300. PubMed ID: 22305531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of paroxysmal nocturnal haemoglobinuria: a personal view.
    Luzzatto L; Gianfaldoni G; Notaro R
    Br J Haematol; 2011 Jun; 153(6):709-20. PubMed ID: 21517820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.